D-Dimer Level and Neutrophils Count as Predictive and Prognostic Factors of Pulmonary Embolism in Severe Non-ICU COVID-19 Patients.
Aged
COVID-19
/ blood
Computed Tomography Angiography
Female
Fibrin Fibrinogen Degradation Products
/ metabolism
Humans
Logistic Models
Male
Middle Aged
Neutrophils
/ pathology
Prognosis
Pulmonary Embolism
/ blood
Retrospective Studies
Risk Factors
SARS-CoV-2
/ genetics
Venous Thromboembolism
/ blood
COVID-19
D-dimer
ICU transfer
anticoagulation
mortality
neutrophil
predictive factor
prognostic
pulmonary embolism
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
26 04 2021
26 04 2021
Historique:
received:
31
03
2021
revised:
23
04
2021
accepted:
23
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
3
6
2021
Statut:
epublish
Résumé
The incidence of pulmonary embolism (PE) is high during severe Coronavirus Disease 2019 (COVID-19). We aimed to identify predictive and prognostic factors of PE in non-ICU hospitalized COVID-19 patients. In the retrospective multicenter observational CLOTVID cohort, we enrolled patients with confirmed RT-PCR COVID-19 who were hospitalized in a medicine ward and also underwent a CT pulmonary angiography for a PE suspicion. Baseline data, laboratory biomarkers, treatments, and outcomes were collected. Predictive and prognostics factors of PE were identified by using logistic multivariate and by Cox regression models, respectively. A total of 174 patients were enrolled, among whom 86 (median [IQR] age of 66 years [55-77]) had post-admission PE suspicion, with 30/86 (34.9%) PE being confirmed. PE occurrence was independently associated with the lack of long-term anticoagulation or thromboprophylaxis (OR [95%CI], 72.3 [3.6-4384.8]) D-dimers ≥ 2000 ng/mL (26.3 [4.1-537.8]) and neutrophils ≥ 7.0 G/L (5.8 [1.4-29.5]). The presence of these two biomarkers was associated with a higher risk of PE (
Identifiants
pubmed: 33926038
pii: v13050758
doi: 10.3390/v13050758
pmc: PMC8146364
pii:
doi:
Substances chimiques
Fibrin Fibrinogen Degradation Products
0
fibrin fragment D
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Références
Blood. 2020 Sep 3;136(10):1169-1179
pubmed: 32597954
Thromb Res. 2020 Dec;196:67-74
pubmed: 32853978
Eur J Radiol. 2020 Nov;132:109336
pubmed: 33069986
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
Thromb Res. 2020 Dec;196:209-212
pubmed: 32911392
Crit Care. 2020 Nov 23;24(1):653
pubmed: 33225952
J Infect Dis. 2020 Nov 9;222(11):1789-1793
pubmed: 32812049
Eur J Haematol. 2021 Feb;106(2):165-174
pubmed: 33043484
J Intensive Care. 2020 Jul 10;8:49
pubmed: 32665858
BMJ. 2021 Feb 11;372:n311
pubmed: 33574135
J Infect Dis. 2021 Mar 29;223(6):933-944
pubmed: 33280009
PLoS One. 2020 Aug 25;15(8):e0238216
pubmed: 32841275
Int J Mol Sci. 2020 Oct 26;21(21):
pubmed: 33114676
Thromb Res. 2020 Sep;193:166-169
pubmed: 32707275
J Thromb Thrombolysis. 2020 Oct 6;:
pubmed: 33025502
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
J Thromb Thrombolysis. 2021 Jan;51(1):40-46
pubmed: 32613385
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Eur Heart J. 2020 Jul 1;41(32):3058-3068
pubmed: 32656565
N Engl J Med. 2020 Jul 9;383(2):120-128
pubmed: 32437596
J Am Coll Cardiol. 2020 Oct 20;76(16):1815-1826
pubmed: 32860872
J Thromb Thrombolysis. 2020 Jul;50(1):211-216
pubmed: 32451823
J Thromb Haemost. 2020 Sep;18(9):2391-2399
pubmed: 32558198
Eur Respir J. 2020 Oct 22;56(4):
pubmed: 32907890
Ann Intern Med. 2007 Oct 16;147(8):W163-94
pubmed: 17938389
J Thromb Haemost. 2020 May;18(5):1023-1026
pubmed: 32338827
Eur Radiol. 2020 Sep;30(9):4903-4909
pubmed: 32314058
Thromb Res. 2020 Dec;196:318-321
pubmed: 32977130
Thromb Res. 2020 Jul;191:9-14
pubmed: 32353746
Radiology. 2020 Sep;296(3):E189-E191
pubmed: 32324102
BMJ. 2020 Mar 26;368:m1091
pubmed: 32217556
J Cardiothorac Vasc Anesth. 2021 Jan 13;:
pubmed: 33518461
J Thromb Haemost. 2020 Aug;18(8):1995-2002
pubmed: 32369666
Eur Respir J. 2020 Jul 30;56(1):
pubmed: 32398297
Emerg Radiol. 2020 Dec;27(6):679-689
pubmed: 33025219
Respir Res. 2020 Jul 3;21(1):169
pubmed: 32620118
Mayo Clin Proc Innov Qual Outcomes. 2021 Apr;5(2):388-402
pubmed: 33585800
J Thromb Haemost. 2020 May;18(5):1094-1099
pubmed: 32220112
Clin Transl Sci. 2020 Nov;13(6):1087-1095
pubmed: 32881340
Thromb Haemost. 2020 Dec;120(12):1597-1628
pubmed: 32920811
Front Med (Lausanne). 2021 Jan 18;7:597791
pubmed: 33537326
Front Med (Lausanne). 2020 Aug 25;7:557
pubmed: 32984388
Am J Ther. 2020 Nov/Dec;27(6):e599-e610
pubmed: 33156016
Thromb Haemost. 2021 Jan 05;:
pubmed: 33401332
J Thromb Thrombolysis. 2020 Aug;50(2):298-301
pubmed: 32476080
J Infect. 2021 Feb;82(2):261-269
pubmed: 33440207
Sci Immunol. 2021 Mar 10;6(57):
pubmed: 33692097
Thromb Haemost. 2017 Feb 28;117(3):437-444
pubmed: 27975101
BMJ. 2019 Jan 9;364:k4810
pubmed: 30626577